Xu Lin
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 14
- Hepatitis C virus research 12
- Epidemiology 42
- Hepatitis B Virus Studies 28
- Liver Disease Diagnosis and Treatment 16
- Co-authors
- Wannan ChenYunli WuJianyin LinXinjian LinWansong LinXian‐E PengQingling HuangQiaojia Huang
- Journals
- Journal of Virology (8 papers)Journal of Medical Virology (5 papers)Oncotarget (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xu Lin
78 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 102
- Hepatology 286
- Cancer Research 295
- Epidemiology 552
- Molecular Biology 798
- Clinical Biochemistry 71
Countries citing papers authored by Xu Lin
This map shows the geographic impact of Xu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Lin more than expected).
Fields of papers citing papers by Xu Lin
This network shows the impact of papers produced by Xu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Lin. The network helps show where Xu Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2019 | 23 | |
| 3 | 2018 | 27 | |
| 4 | 2018 | 25 | |
| 5 | 2017 | 17 | |
| 6 | 2016 | 1 | |
| 7 | 2015 | 16 | |
| 8 | 2015 | 15 | |
| 9 | 2013 | 31 | |
| 10 | 2011 | 18 | |
| 11 | 2011 | 22 | |
| 12 | 2011 | 34 | |
| 13 | 2010 | 11 | |
| 14 | 2010 | 13 | |
| 15 | 2010 | 7 | |
| 16 | 2010 | 11 | |
| 17 | 2009 | 46 | |
| 18 | Meta-analysis of case-control studies on the dual infection of hepatitis B and C virus in carcinogenesis of hepatocellular carcinoma in China | 2008 | 1 |
| 19 | 2008 | 43 | |
| 20 | 2008 | 27 |
About Xu Lin
Xu Lin is a scholar working on Hepatology, Epidemiology, Cancer Research, Aging and Molecular Biology, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (28 papers), Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (12 papers), Ubiquitin and proteasome pathways (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers), NF-κB Signaling Pathways (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Hepatology (286 citations), Cancer Research (295 citations), Epidemiology (552 citations), Molecular Biology (798 citations) and Clinical Biochemistry (71 citations). Xu Lin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Wannan Chen, Yunli Wu, Jianyin Lin, Xinjian Lin, Wansong Lin, Xian‐E Peng, Qingling Huang, Qiaojia Huang, Lu Cai and Yu‐Mei Wen. Their work appears in journals such as Journal of Virology, Journal of Medical Virology, Oncotarget, Journal of Cancer Research and Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.